著者

HIROKI SHIMURA SHINICHI SUZUKI TOSHIHIKO FUKUSHIMA SANAE MIDORIKAWA SATORU SUZUKI NAOMI HAYASHIDA MISA IMAIZUMI NORIYUKI OKUBO YASUSHI ASARI TAKESHI NIGAWARA FUMIHIKO FURUYA KAZUHIKO KOTANI SHIGEYUKI NAKAJI AKIRA OTSURU TAKASHI AKAMIZU MASAFUMI KITAOKA NOBORU TAKAMURA MASAFUMI ABE HITOSHI OHTO NOBUYUKI TANIGUCHI SHUNICHI YAMASHITA

出版者

福島医学会

雑誌

FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (ISSN:00162590)

巻号頁・発行日

pp.2014-28, (Released:2014-12-20)

参考文献数

33

被引用文献数

4

---

Contents1. Introduction2. Thyroid ultrasound examination in Fukushima3. Thyroid ultrasound findings in children in three Japanese prefectures4. Prevalence of thyroid nodular lesions in children and adolescents 4.1 Thyroid cyst 4.2 Thyroid nodule 4.3 Thyroid cancer5. SummaryConflict of interestReference

著者

HIROKI SHIMURA SHINICHI SUZUKI TOSHIHIKO FUKUSHIMA SANAE MIDORIKAWA SATORU SUZUKI NAOMI HAYASHIDA MISA IMAIZUMI NORIYUKI OKUBO YASUSHI ASARI TAKESHI NIGAWARA FUMIHIKO FURUYA KAZUHIKO KOTANI SHIGEYUKI NAKAJI AKIRA OTSURU TAKASHI AKAMIZU MASAFUMI KITAOKA NOBORU TAKAMURA MASAFUMI ABE HITOSHI OHTO NOBUYUKI TANIGUCHI SHUNICHI YAMASHITA

出版者

THE FUKUSHIMA SOCIETY OF MEDICAL SCIENCE

雑誌

FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (ISSN:00162590)

巻号頁・発行日

vol.60, no.2, pp.196-202, 2014 (Released:2015-02-26)

参考文献数

33

被引用文献数

4

---

Contents1. Introduction2. Thyroid ultrasound examination in Fukushima3. Thyroid ultrasound findings in children in three Japanese prefectures4. Prevalence of thyroid nodular lesions in children and adolescents 4.1 Thyroid cyst 4.2 Thyroid nodule 4.3 Thyroid cancer5. SummaryConflict of interestReference

著者

Hiroyuki Ariyasu Hiroshi Iwakura Naoichiro Yukawa Toshinori Murayama Masayuki Yokode Harue Tada Kenichi Yoshimura Satoshi Teramukai Tatsuya Ito Akira Shimizu Atsushi Yonezawa Kenji Kangawa Tsuneyo Mimori Takashi Akamizu

出版者

(社)日本内分泌学会

雑誌

Endocrine Journal (ISSN:09188959)

巻号頁・発行日

pp.EJ14-0088, (Released:2014-04-17)

被引用文献数

6 20

---

The majority of patients with systemic sclerosis (SSc) have gastrointestinal (GI) tract involvement, but therapies using prokinetic agents are usually unsatisfactory. Ghrelin stimulates gastric motility in healthy human volunteers. In this study, we investigated whether ghrelin could improve gastric emptying in patients with gastrointestinal symptoms due to SSc. The study was performed in a randomized, double-blind, placebo-controlled crossover fashion on two occasions. Ten SSc patients with GI tract involvement received an infusion of either ghrelin (5.0 μg/kg) or saline, and gastric emptying rate was evaluated by 13C-acetic acid breath test. Gastric emptying was significantly accelerated by ghrelin infusion in patients with SSc (ghrelin vs. saline: 43.3 ± 11.4 min vs. 53.4 ± 5.4 min, P≡0.03). No serious adverse effects were observed. Our results suggest that ghrelin might represent a new therapeutic approach for GI tract involvement in patients with SSc.

著者

Hidefumi Inaba Hiroyuki Ariyasu Hiroshi Iwakura Chiaki Kurimoto Ken Takeshima Shuhei Morita Hiroto Furuta Muneki Hotomi Takashi Akamizu

出版者

The Japan Endocrine Society

雑誌

Endocrine Journal (ISSN:09188959)

巻号頁・発行日

pp.EJ20-0371, (Released:2020-10-03)

被引用文献数

24

---

Immune-related adverse events in the thyroid glands (thyroid irAEs) during treatment with immune-checkpoint inhibitors (ICIs) are most frequent endocrine irAE. Thyroid irAE can be divided into that requiring continuous therapy for thyroid dysfunction (P-THY), and that requiring only temporal treatment (T-THY). However, predictive factors for those differential outcomes are unknown, and susceptibility of human leukocyte antigen (HLA) to thyroid irAE has never been investigated. This study aimed to elucidate clinical courses and prognosis of P-THY in comparison with T-THY in the aspect of thyroid immunity and HLA. Patients with P-THY (n = 15) that required L-T4 supplemental therapy for hypothyroidism for more than 3 months, and patients with T-THY who required no therapy or therapy within 1 month were enrolled in the study. Lower-value of TSH, higher-value of FT4, and lower value of TSH/FT4 were thought to be predictive markers to estimate P-THY. In addition, anti-thyroglobulin antibody (TgAb) levels were significantly higher in patients with P-THY than those in patients with T-THY. HLA-DPA1*01:03 and HLA-DPB1*02:01 allele, and their haplotype frequencies were significantly higher in patients with P-THY than those in controls. P-THY had better survival rate than T-THY. Pre-existing thyroid autoimmunity, the extent of thyroid dysfunction, and predisposing HLA were associated with the differential course of thyroid irAEs. It was suggested that thyroid function tests, TgAb, and HLA typing tests are useful for prediction of clinical course in thyroid irAEs.

著者

Sawako Takahashi Mitsuru Ito Yuzuki Masaki Mikiko Hada Mizuho Minakata Kazuyoshi Kohsaka Tomohiko Nakamura Toshihiko Kasahara Takumi Kudo Eijun Nishihara Shuji Fukata Mitsushige Nishikawa Takashi Akamizu Akira Miyauchi

出版者

The Japan Endocrine Society

雑誌

Endocrine Journal (ISSN:09188959)

巻号頁・発行日

pp.EJ20-0542, (Released:2020-11-25)

被引用文献数

1

---

Many previous studies including ours have reported that athyreotic patients on levothyroxine (LT4) have relatively low serum free triiodothyronine (FT3) levels, whereas patients with large goitrous diseases often have high serum FT3 levels. Here we investigated Hashimoto thyroiditis (HT) patients on LT4 to study the relationship between thyroid volume (TV) and thyroid hormone status in hypothyroid patients on LT4. We retrospectively studied 408 euthyroid HT patients treated with LT4 for hypothyroidism; divided them as per TV and compared serum levels of free thyroxine (FT4) and FT3 and the FT3/FT4 ratio in each patient group with those in euthyroid matched control group. We also evaluated the association between serum FT3 level and FT3/FT4 ratio and TV among HT patients on LT4. In patients with TV <15 mL, serum FT3 levels were significantly lower than those in controls. In patients with TV 15–80 mL, serum FT3 levels were equivalent to those in controls. In patients with TV ≥80 mL, the serum FT3 levels were significantly higher than those in controls. The serum FT3 level (r = 0.35, p < 0.01) and FT3/FT4 ratio (r = 0.42, p < 0.01) showed a positive correlation with TV. TVs in HT patients on LT4 caused differences in serum thyroid hormone balance, as increasing volume increases the serum FT3 level and FT3/FT4 ratio. Serum thyroid hormone balance in HT patients with smaller thyroids was similar to that in athyreotic patients. Mild thyrotropin suppression with LT4 is needed to achieve normal FT3 levels in such patients.